Literature DB >> 2859502

Smoking, gastric secretion, and inhibition by H2 receptor antagonists.

M Deakin, J Ramage, S P Gray, J Billings, D Colin-Jones, J G Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2859502     DOI： 10.1016/s0140-6736(85)91654-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Effect of enprostil, a synthetic prostaglandin E2 on 24 hour intragastric acidity, nocturnal acid and pepsin secretion.

Authors:  M Deakin; J Ramage; A Paul; S P Gray; J Billings; J G Williams
Journal:  Gut       Date:  1986-09       Impact factor: 23.059

Review 2.  Optimizing acid suppression for treatment of acid-related diseases.

Authors:  R H Hunt; C Cederberg; J Dent; F Halter; C Howden; I N Marks; S Rune; R P Walt
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

3.  Does smoking influence the pharmacokinetics and pharmacodynamics of the H2-receptor antagonist famotidine?

Authors:  L C Baak; S Ganesh; J B Jansen; C B Lamers
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.